Cite

HARVARD Citation

    Hormi, M. et al. (2020). Pairing MCL‐1 inhibition with venetoclax improves therapeutic efficiency of BH3‐mimetics in AML. European journal of haematology. pp. 588-596. [Online]. 
  
Back to record